Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification

Fig. 6

Subgroups prognostic, univariate, multivariate Cox regression,and nomogram analysis of PROS1 in LGG. AE Kaplan–Meier curves of high and low PROS1 expression in subgroups, including female (A), Age > 40 years (B), 1p/19q non-codeletion (C), SD&PD (D), and astrocytoma (E). FG The univariate F and multivariate Cox regression G analysis of PRSO1 in LGG patients. HI Risk factor associations diagram H and Sankey diagram I were used to depicted the overall prognostic trend and living status of the inner relationship. J The nomogram for predicting the probability of 1-, 3-, and 5- year OS for LGG patients. K Calibration plots of the nomogram for predicting the probability of OS at 1, 3, and 5 years

Back to article page